UpFront
-
Ten interesting things we read this week
Some of the most fascinating topics covered this week are: Digital Art (Making millions selling pixels), Communication (Persuading the unpersuadable), Social Media (Apple vs Facebook) and Economy (Why central banks love printing money).
-
China sets economic growth target of 'over 6%' this year
China's growth target comes as the virus has been all but halted within its borders, and as the number of cases has fallen steeply in recent weeks in countries like the United States and India
-
One and done: Why people are eager for Johnson & Johnson's vaccine
Apart from the vaccine offering the convenience of a single shot, it will also allow governments to slash costs for staffing and operations related to the second doses
-
OTT platforms ask for more time to comply, MIB remains non-committal
Industry seeks more clarity, expresses concerns about newly notified Digital Media Code of Ethics in a closed-door meeting with the minister
-
'She is a hero': In Myanmar's protests, women are on the front lines
Despite the risks, women have stood at the forefront of Myanmar's protest movement, sending a powerful rebuke to the generals who ousted a female civilian leader and reimposed a patriarchal order that has suppressed women for half a century
-
Brazil's Covid-19 crisis is a warning to the whole world, scientists say
No other nation that experienced such a major outbreak is still grappling with record-setting death tolls and a health care system on the brink of collapse
-
Razorpay's 'full stack' ambition
The fintech unicorn has gone beyond payments into neobanking and facilitating loans and insurance. The dream is to become the only financial platform a business will ever need
-
EXPLAINER: What is vaccine efficacy and what does it mean?
As Covaxin shows vaccine efficacy of 81 percent, a look at what efficacy means, how it is calculated, the difference between efficacy and efficiency, and more
-
Krishna Ella: How a farmer's son gave India its first successful indigenous Covid-19 vaccine
As Bharat Biotech's Covaxin shows an interim efficacy of 81 percent, Forbes India traces the career of the founder, whose entrepreneurial journey has seen a successful track record of developing vaccines in India for the world
-
.jpg?impolicy=website&width=360&height=270 "Shiv Shivakumar: How to deal with the ten most important career dilemmas")
Shiv Shivakumar: How to deal with the ten most important career dilemmas
All of us go through career dilemmas at some point. Shivakumar discusses the top ten dilemmas that we may experience and backs them with research and data to analyse how we can make better career moves. In his book, 'The Right Choice', he says India produces nearly half a million MBAs every year but less than 5 percent of an IIM batch makes it to the CEO's office, thus explaining that merely possessing a degree from a prestigious institute does not guarantee a ticket to the corner office. He discusses the importance of career moves, board membership and CEO's dilemmas
-
Plan to ditch the mask after vaccination? Not so fast
While all of the Covid-19 vaccines are spectacularly good at shielding people from severe illness and death, scientists do not know whether vaccinated people spread the virus to those who are unvaccinated